Smith Nephew Plc Stock Today

SNNUF Stock  USD 13.15  1.09  9.04%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Smith Nephew is trading at 13.15 as of the 19th of January 2025. This is a 9.04 percent increase since the beginning of the trading day. The stock's lowest day price was 13.15. Smith Nephew has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 19th of January 2025. Click here to learn more.
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 873.35 M outstanding shares. More on Smith Nephew plc

Moving against Smith Pink Sheet

  0.64AROC ArchrockPairCorr
  0.59SLF Sun Life FinancialPairCorr
  0.53BSX Boston Scientific CorpPairCorr
  0.39SIGL Signal AdvancePairCorr
  0.38SYK StrykerPairCorr
  0.38DXCM DexCom IncPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Smith Pink Sheet Highlights

Business ConcentrationMedical Devices, Healthcare (View all Sectors)
Smith Nephew plc [SNNUF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Smith Nephew's market, we take the total number of its shares issued and multiply it by Smith Nephew's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Smith Nephew plc classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 873.35 M outstanding shares. Smith Nephew plc has accumulated about 516 M in cash with 877 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check Smith Nephew Probability Of Bankruptcy
Ownership Allocation
Smith Nephew plc shows a total of 873.35 Million outstanding shares. Over half of Smith Nephew's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Smith Ownership Details

Smith Nephew plc Risk Profiles

Smith Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Smith Nephew without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Smith Nephew Corporate Management

Other Information on Investing in Smith Pink Sheet

Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.